Gadobutrol (Gadavist, Gadovist, BAY86-4875)
91782
Phase 3 small_molecule completed
Quick answer
Gadobutrol (Gadavist, Gadovist, BAY86-4875) for Breast Cancer is a Phase 3 program (small_molecule) at Bayer HealthCare AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bayer HealthCare AG
- Indication
- Breast Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed